6.16
Nuvectis Pharma Inc (NVCT) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Research and Development |
1.82%
3.613
|
3.68 | 4.496 | 2.819 | 2.943 |
Operating Income/Loss |
18.44%
-6.595
|
-5.568 | -6.449 | -4.359 | -4.643 |
Income/Loss From Continuing Operations Before Tax |
18.79%
-6.334
|
-5.332 | -6.248 | -4.153 | -4.428 |
Income/Loss From Continuing Operations After Tax |
18.79%
-6.334
|
-5.332 | -6.248 | -4.153 | -4.428 |
|
18.79%
-6.334
|
-5.332 | -6.248 | -4.153 | -4.428 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
7.17%
21.37
|
19.94 | 0.2151 | 17.23 | 16.90 |
Diluted Average Shares |
7.17%
21.37
|
19.94 | 0.2151 | 17.23 | 16.90 |
Basic Earnings Per Share |
11.11%
-0.30
|
-0.27 | -0.36 | -0.24 | -0.26 |
Diluted Earnings Per Share |
11.11%
-0.30
|
-0.27 | -0.36 | -0.24 | -0.26 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):